An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies

Overview of attention for article published in Core Evidence, March 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 67 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,355 followers.

An #EvidenceBased #review of #obatoclax #mesylate in the #treatment of #hematological #malignancies: http://t.co/j6O5kw9DSG

Reply Repost Favourite